Get latest articles and stories on Business at LatestLY. Geneva [Switzerland], October 2: Swiss-based medical technology company MedAlliance has been acquired by Cordis for a 2022 investment of USD 35M and a 2023 upfront closing payment of USD 200M, together with regulatory achievement milestones of up to USD 125M and commercial milestones of up to USD 775M through 2029, for a total consideration of up to USD 1.135 Billion. Business News | MedAlliance Acquired by Cordis for Up to USD 1.135 Billion.
/PRNewswire/ Cordis, a worldwide leader in the development and manufacturing of interventional cardiovascular and endovascular technology, today announced.
Cordis, a worldwide leader in the development and manufacturing of interventional cardiovascular and endovascular technology, today announced the appointment of Scott Drake as Executive Chairman of its Board of Directors. Drake, who joined the Cordis board in August of 2021, succeeds Duke Rohlen who served as Executive Chairman since the acquisition of Cordis, also in 2021, by Hellman & Friedman and KKR. Mr. Rohlen will remain a member of the Cordis Board of Directors and will continue to serve